Blue Fin Capital’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.27M Buy
+10,056
New +$1.27M 0.22% 68
2024
Q4
$1.36M Sell
10,319
-160
-2% -$21.2K 0.25% 64
2024
Q3
$1.53M Sell
10,479
-37
-0.4% -$5.39K 0.29% 59
2024
Q2
$1.44M Buy
10,516
+74
+0.7% +$10.2K 0.29% 60
2024
Q1
$1.43M Sell
10,442
-301
-3% -$41.3K 0.32% 56
2023
Q4
$1.46M Sell
10,743
-544
-5% -$73.9K 0.37% 54
2023
Q3
$1.38M Sell
11,287
-554
-5% -$67.7K 0.4% 57
2023
Q2
$1.5M Buy
11,841
+260
+2% +$33K 0.43% 53
2023
Q1
$1.51M Buy
11,581
+288
+3% +$37.5K 0.49% 47
2022
Q4
$1.48M Sell
11,293
-275
-2% -$36.1K 0.54% 48
2022
Q3
$1.35M Sell
11,568
-492
-4% -$57.5K 0.51% 51
2022
Q2
$1.42M Buy
12,060
+589
+5% +$69.3K 0.5% 52
2022
Q1
$1.49M Sell
11,471
-4,566
-28% -$595K 0.43% 56
2021
Q4
$2.45M Buy
16,037
+3,721
+30% +$568K 0.68% 38
2021
Q3
$1.99M Buy
12,316
+1,504
+14% +$243K 0.61% 42
2021
Q2
$1.77M Buy
10,812
+112
+1% +$18.3K 0.55% 46
2021
Q1
$1.61M Buy
10,700
+720
+7% +$108K 0.55% 50
2020
Q4
$1.51M Buy
9,980
+1,030
+12% +$156K 0.54% 50
2020
Q3
$1.21M Sell
8,950
-580
-6% -$78.5K 0.49% 52
2020
Q2
$1.3M Buy
9,530
+3,222
+51% +$440K 0.58% 47
2020
Q1
$679K Buy
6,308
+154
+3% +$16.6K 0.37% 70
2019
Q4
$737K Buy
6,154
+806
+15% +$96.5K 0.35% 78
2019
Q3
$532K Sell
5,348
-400
-7% -$39.8K 0.28% 85
2019
Q2
$627K Buy
5,748
+351
+7% +$38.3K 0.32% 80
2019
Q1
$603K Buy
5,397
+1,967
+57% +$220K 0.32% 81
2018
Q4
$330K Sell
3,430
-1,566
-31% -$151K 0.2% 104
2018
Q3
$609K Buy
+4,996
New +$609K 0.3% 77